\
&
Contact us
\
&
Contact us
Published on | 5 years ago
Programmes EIC PilotThe report focuses on the results and impacts of the European Innovation Council (EIC) Pilot (2018 – 2020) and its predecessor programmes since 2014, against a set of Key Performance Indicators. The EIC supports both breakthrough research (the EIC Pathfinder, building on the Future and Emerging Technologies programme) and the scale up of innovative startups and SMEs (the EIC Accelerator, building on the former SME instrument). The report offers insights into the profiles of the beneficiaries funded under the European Innovation Council.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
